Webinar: Achieving quality cell and gene therapies outcomes through multidisciplinary collaboration
1:02:57
Description
Related Videos
View More
View Less
1:02:57
59:59
With the right planning and understanding, collaboration between drug development companies and patient advocacy groups (PAGs) can be mutually beneficial in a number of key areas.
1:02:03
1:01:11
57:01
1:14:41
With the right planning and understanding, collaboration between drug development companies and patient advocacy groups (PAGs) can be mutually beneficial in a number of key areas.
1:02:03